Aspira Women's Health Inc.
AWHL
$0.27
-$0.03-10.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.05M | 1.97M | 2.23M | 2.31M | 2.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.05M | 1.97M | 2.23M | 2.31M | 2.40M |
| Cost of Revenue | 915.00K | 896.00K | 790.00K | 922.00K | 870.00K |
| Gross Profit | 1.13M | 1.07M | 1.44M | 1.38M | 1.53M |
| SG&A Expenses | 2.32M | 2.10M | 2.31M | 2.25M | 2.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.88M | 4.17M | 3.51M | 3.88M | 4.21M |
| Operating Income | -1.84M | -2.20M | -1.28M | -1.58M | -1.81M |
| Income Before Tax | -2.42M | 676.00K | -3.37M | -4.89M | -2.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.42M | 676.00K | -3.37M | -4.89M | -2.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.42M | 676.00K | -3.37M | -4.89M | -2.67M |
| EBIT | -1.84M | -2.20M | -1.28M | -1.58M | -1.81M |
| EBITDA | -1.80M | -2.16M | -1.27M | -1.53M | -1.80M |
| EPS Basic | -0.05 | 0.02 | -0.08 | -0.13 | -0.08 |
| Normalized Basic EPS | -0.03 | 0.01 | -0.06 | -0.08 | -0.05 |
| EPS Diluted | -0.05 | -0.05 | -0.08 | -0.13 | -0.08 |
| Normalized Diluted EPS | -0.03 | 0.01 | -0.06 | -0.08 | -0.05 |
| Average Basic Shares Outstanding | 44.25M | 43.49M | 42.80M | 36.39M | 35.56M |
| Average Diluted Shares Outstanding | 44.25M | 45.77M | 42.80M | 36.39M | 35.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |